18.02.2013 Views

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

Tobacco and Public Health - TCSC Indonesia

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Introduction<br />

Chapter 32<br />

<strong>Tobacco</strong> <strong>and</strong> cardiovascular disease<br />

Konrad Jamrozik<br />

At the level of the whole population, tobacco causes far more harm via its contribution<br />

to cardiovascular disease (CVD) than it does through its effects on either the risk of<br />

lung cancer or of chronic obstructive pulmonary disease (COPD). This occurs because,<br />

in the absence of smoking, lung cancer <strong>and</strong> COPD are both very rare conditions. CVD,<br />

by contrast, is now the commonest cause of death of Homo sapiens (World <strong>Health</strong><br />

Organization 1999). Thus, for a given prevalence of smoking in a population, the small<br />

increase in risk of CVD, in relative terms, that is associated with smoking generates<br />

many additional cases of CVD. By contrast, the much larger relative risks for lung<br />

cancer <strong>and</strong> COPD associated with smoking generate fewer additional cases of these<br />

conditions because these risks are applied to ‘background’ incidence rates that are<br />

much lower than the lifetime risk of CVD in non-smokers (Wald 1978).<br />

Nevertheless, <strong>and</strong> despite some relationship between smoking <strong>and</strong> heart disease<br />

having been described for at least a century (Bruce 1901), more than twenty years<br />

elapsed between publication of the original report on the effects of smoking <strong>and</strong> health<br />

by the Royal College of Physicians of London (1962), which concentrated on lung<br />

cancer, <strong>and</strong> the appearance of a report from the Surgeon-General of the United States<br />

dedicated to the adverse effects of smoking on the cardiovascular system (United States<br />

Department of <strong>Health</strong> <strong>and</strong> Human Services 1983). Even the latter report is remarkable<br />

for the number of aspects of CVD about which information on the impact of smoking<br />

was either entirely lacking or inadequate to draw firm conclusions. This emphasizes how<br />

much more was learnt about active smoking <strong>and</strong> CVD in the last two decades of the<br />

twentieth century. That picture is now very close to complete, although, as this chapter<br />

will show, some significant questions remain unanswered <strong>and</strong>, arguably, we have yet to<br />

distil all of the lessons that might be taught by the knowledge that we have available.<br />

To some extent, history has repeated itself in relation to passive smoking. The first<br />

reports of an increased incidence of major respiratory illness in infants <strong>and</strong> children who<br />

were passive smokers appeared in the English-language literature in 1974 (Colley et al.<br />

1974; Harlap <strong>and</strong> Davies 1974), <strong>and</strong> data implicating passive smoking as a cause of lung<br />

cancer in adults were first published in 1981 (Hiryama 1981; Trichopoulos et al. 1981).<br />

However, another four years elapsed before equivalent studies of CVD appeared<br />

(Garl<strong>and</strong> et al. 1985), even though a literature on the short-term consequencesofpassive

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!